Yale Scientists Reveal Molecular Pathway for Smarter Breast Cancer Drugs
New research at Yale has revealed major differences in aggressive types of breast cancer, and the potential for smarter treatments for patients. Triple-negative breast cancer, which has a low survival rate and a lack of helpful molecular biomarkers — specific proteins that signal the presence of disease — is among the most aggressive breast cancer subtypes.Source: Yale West Campus News
Geneticist Sidi Chen Receives Large Award Which Will Further His Breast Cancer Work
This Department of Defense award goes to the “best and brightest in their fields,” and recognizes “creative and innovative individuals.” Investigators are chosen for their ability “to go beyond conventional thinking” in their respective areas of expertise.
Yale enhances its cytometry capabilities
The methods and equipment used to probe cellular questions are rapidly advancing—including, at Yale, through the addition in 2014 of CyTOF, or Cytometry Time-Of-Flight, and this past June of the CyTOF Imaging Mass Cytometer (IMC), which greatly expands Yale's ability to examine specimens that are analyzed both for clinical diagnosis and for basic research.Source: Medicine@Yale
Twenty years and counting for Women's Health Research at Yale
Women’s Health Research at Yale (WHRY), a self-supporting center within Yale School of Medicine, will celebrate its 20th anniversary in February. With data developed through $5 million in WHRY grants to date, Yale scientists have gone on to secure $95 million in external grants to further their research into women’s health.Source: Medicine@Yale
Yale Cancer Center research highlighted at 2017 SABCS
Yale Cancer Center (YCC) researchers attended the 40th annual San Antonio Breast Cancer Symposium (SABCS), from December 5-9, and bringing news of major advances against a disease that strikes more than 250,000 women and men in the United States each year. The Symposium is a five-day program attended by an international audience of academic and private researchers and physicians from over 90 countries.
Yale team finds why BRCA gene resists cancer treatment
Yale University researchers have discovered why a key molecular assistant is crucial to the function of the BRCA2 gene, which in some mutant forms can lead to ovarian and breast cancer in as many as 6 in 10 women. The findings suggest how biochemists might be able to decrease drug resistance to existing therapies that target this form of cancer, the authors report in the July 2 issue of the journal Molecular Cell.
WHRY-Funded Investigator Reducing the Confusion In Genetic Testing for Breast Cancer Risk
Dr. Ryan Jensen knows, having devoted much of his health research career to studying the intricacies of the BRCA2 gene, providing clear answers about breast cancer risk based on genetic testing can be problematic.
How Much Can Women Trust That Breast Cancer Biopsy?
When a woman is diagnosed with breast cancer, the person who does the diagnosing is a doctor she never sees — the pathologist. But though pathologists do a great job of identifying invasive cancer, they aren't as good at spotting two less clear-cut diagnoses that bring women a lot of uncertainty and worry, a study finds.Source: NPR
News Study: Biopsy Specialists Frequently Misdiagnose Breast Tissue
Here’s another reason for getting a second medical opinion: Biopsy specialists frequently misdiagnose breast tissue, potentially leading to too-aggressive treatment for some women and under-treatment for others, a study suggests.Source: CBS News
Yale Cancer Center Researchers Identify Possible Target for Immunotherapy in Early-Stage Breast Cancer
Yale Cancer Center researchers have identified a method of accurately detecting the level antibody PDL-1 in early-stage breast tumors. This process could lead to a better way of determining which breast cancer patients will respond to new immune therapy drugs.
Women's Health Research at Yale: 2013 Pilot Project Awards Announced
This year’s content areas include breast cancer, the second leading cause of cancer deaths in women; autoimmune diseases, more common in women than men, including antiphospholipid syndrome, (or APS), which can cause stroke, heart attack and pregnancy-related problems, and lupus; HIV prevention, as HIV is far more prevalent among young black women than other young women, and sexually transmitted infections that affect more women than men and currently have no cure or intervention to prevent recur
Facing Financial Toxicity in Cancer Care
Patients with cancer often face another challenge: financial toxicity. And while demographics like tumor stage and treatment can influence this, one expert says there are ways to mitigate or plan for the costly effects of cancer treatment.Source: Cure Today
BCRF Congratulates Dr. Eric P. Winer on Prestigious Appointment at Yale
BCRF is thrilled to share that Dr. Eric P. Winer has been named the next director of the Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital at Yale New Haven—a fitting appointment for his distinguished career and contributions to cancer research.Source: Breast Cancer Research Foundation
Pandemic Delayed at Least 18,000 Mammograms in CT; Appointments Opening Up
With a radiology van and multiple locations in New Haven and Fairfield counties, Yale Radiology has caught up significantly on the 18,000 mammograms that were delayed after March 2020, according to Dr. Regina Hooley, interim breast imaging division chief.Source: CT Post
Dr. Maryam Lustberg Of Yale Cancer Center On The 5 Things Everyone Needs To Know About Cancer
A cancer diagnosis does not define us. A cancer diagnosis is scary and overwhelming. Yet who we are as individuals is not defined by a diagnosis, but how we move forward and what we want our future look like.Source: Authority Magazine
Stop Breast Cancer in its Tracks
The importance of getting a routine mammogram cannot be overstated. It can save your life. “Breast cancer can best be treated when diagnosed at its earliest stages,” said Melanie Lynch, MD, director of breast surgery at Bridgeport Hospital’s Norma Pfriem Breast Center and Smilow Cancer Hospital Care Center at Park Avenue Medical Center in Trumbull. “Recent studies suggest that even a three-month delay in diagnosis and treatment may lead to a more advanced stage of breast cancer at the time it is discovered.”Source: Yale New Haven Health